| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_658df3b9d24eb5224b37aaf605741db6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_018ebde15fc290feb420f966880bcf40 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04cc469449ba42a0a4a021b680d4a2fc |
| publicationDate |
2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012129399-A2 |
| titleOfInvention |
Compositions for and methods of evaluating tumors having a skeletal muscle origin |
| abstract |
Myoblastic differentiation biomarkers are provided for evaluating tumors having a skeletal muscle origin. In addition, kits are provided for evaluating expression levels or presence of the biomarkers associated with such tumors. Furthermore, methods are provided for evaluating such tumors via measuring expression levels or presence of the biomarkers in the cytoplasm of cells. |
| priorityDate |
2011-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |